Skip to main content

Table 4 Acute (A) and late (B) non-hematologic toxicity (CTCAE,v 4.3), n = 100; n (%)

From: Locally advanced NSCLC: a plea for sparing the ipsilateral normal lung—prospective, clinical trial with DART-bid (dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily) by VMAT

   Grade 1 Grade 2 Grade 3 Grade 4 Grade 5
A Pneumonitis n.a 12 (12) 2 (2)
  Esophagitis 12 (12) 57 (57) 3 (3)
B Bronchial stricture/Atelectasis n.a 2 (2)
  Hemorrhage 2 (2)
  1. CTCAE = Common Terminology Criteria for Adverse Effects; n.a. = not assessed